Enteral Nutrition Market by Protein Composition (Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient and Others), Form (Powder and Liquid), Age Group (Adults, and Pediatric), and Distribution Channel (Hospital Sales, Retail, and Online): Global Opportunity Analysis and Industry Forecast, 2020–2027
The global drug-eluting stents market was valued at $6,762 million in 2018, and is projected to reach $12,294 million by 2027, registering a CAGR of 7.1% from 2020 to 2027.
Enteral nutrition is prescribed to patients, who are unable to consume sufficient nutrients orally but whose gastrointestinal function is a satisfactory condition for digestion and absorption. This process is deployed when a patient is unable to eat due to some illness, has swallowing difficulties, or surgery that may interfere with the normal eating process. The enteral nutrients are administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes. Enteral nutrients are prescribed to patients suffering from chronic illness such as malnutrition, gastrointestinal disorder, cancer, and others. Generally, enteral feeding is deployed in an operation theatre (OT), intensive care unit (ICU), and critical care unit (CCU), and even at home for severely ill patients.
Rise in prevalence of chronic disorders such as cancer and neurological disorders is the major factor that contributes toward the growth of the enteral nutrition market. Other factors that fuel the market growth include increase in geriatric population, and surge in malnutrition cases. Over the years, enteral nutrition is gaining acceptance, owing to the enhancement in techniques, configurations, and ingredients. However, poor demand and lack of awareness of enteral nutrition in underdeveloped countries hamper the market growth. Conversely, development of new technologically advanced products and high market potential in untapped emerging economies are expected to provide lucrative opportunities for the growth of the market.
The enteral nutrition market is segmented into protein composition, form, age group, distribution channel, and region. By protein composition, the market is divided into standard protein diet, high protein supplement, protein for diabetes care patient, and others. By form, the market is bifurcated into powder and liquid. By age group, the market is bifurcated into adults (above 18) and pediatric (below 18). By distribution channel, the market is classified into hospital sales, retail, and online. By region, the enteral nutrition market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2018 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of four regions is provided to determine the existing opportunities.
• Profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Protein Composition • Standard Protein Diet
• High Protein Supplement
• Protein for Diabetes Care Patient
By Form • Powder
By Age Group • Adults (Above 18)
• Pediatric (Below 18)
By Distribution Channel • Hospital Sales
By Region • North America
o Rest of Europe
o South Korea
o Rest of Asia-Pacific
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT • Abbott Laboratories
• B. Braun Melsungen AG
• Danone S.A.
• Fresenius Kabi AG
• Global Health Products, Inc.
• Hormel Foods Corporation
• Meiji Holdings Co., Ltd.
• Nestlé S.A.
• Reckitt Benckinser Group PLC,
• Victus, Inc.
Our reports have been used by over 10K customers, including:
The global microspheres market reached a value of US$ 4.6 Billion in 2020. Microspheres refer to solid sphere-shaped particles available in sizes ranging from 1 to 1000 µm. They are usually made using glass, ceramic, fly ash, metal and polymers and have controlled opacity, particle size distribution, gravity and electrostatic charge. In the...
256 pages •
By Roots Analysis Private Ltd.
• Feb 2021
INTRODUCTION Over time, advances in molecular biology and pharmacological chemistry have enabled the identification of biological targets localized in the subcellular space, and development of therapeutic leads against them. In fact, there are several clinical conditions, which were previously considered undruggable since...
Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Technology (Bluetooth, NFC), By Product (Connected Sensors, Integrated Connected Devices), By End User, And Segment Forecasts, 2021 - 2028
Connected Drug Delivery Devices Market Growth & Trends
The global connected drug delivery...
The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS. There has been a remarkable increase...
Report Scope: The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and drug delivery, and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections. The report...
KEY FINDINGS The global pulmonary drug delivery market is anticipated to register a CAGR of 5.06%, during the forecast years of 2019 to 2028. The key drivers, such as advancements in technology, the surging prevalence of respiratory diseases, and the rising geriatric population, are attributed to market growth. MARKET...
243 pages •
By Roots Analysis Private Ltd.
• Aug 2020
Diabetes is considered to be among the seventh leading causes of mortality worldwide. The chronic and debilitating nature of the condition has a severe impact on the quality of life of patients. According to the World Health Organization (WHO), more than 400 million individuals across the world are currently...
INTRODUCTION Over the years, advances in cell biology and pharmacology have led to the development of a variety of advanced biologics, which experts believe, possess the potential to address several unmet needs associated with the treatment of different types of diseases. Currently, there are more than 1,000 cell and gene...
Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields.The company’s medical specialties include anesthesiology, pain medicine, orthopedic surgery, physical medicine and...
Medical Devices Sales
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.